OT Genome Fund I, LLC — Form D/A
OT Genome Fund I, LLC of Boston, MA, a pooled investment fund, filed a Form D amendment with the SEC on 2021-04-08. The offering totals $3.6M, of which $3.6M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2021-04-08
- Form: D/A
- Accession: 0001841485-21-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C.1
- Total offering: $3.6M
- Amount sold: $3.6M
- Minimum investment: $100K
- Investors: 22
- Date of first sale: 2021-02-03
- Security types: fund interests
- SEC file number: 021-389014
Issuer
- Name: OT Genome Fund I, LLC
- CIK: 0001841485
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 167 W Newton Street, Boston, MA, 02118
- Phone: (408) 396-3123
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| LLC OT Management | Director | Boston, MA |
| LLC Assure Fund Management II | Executive Officer | Salt Lake City, UT |
| Richard Thoms | Executive Officer | Salt Lake City, UT |
Other filings by this issuer (1)
More